Recruiting

Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from past medical records and data - Retrospective
Who is being recruted

Breast Carcinoma In Situ+12

+ Adenocarcinoma

+ Breast Diseases

From 18 to 85 Years
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: May 2023
See protocol details

Summary

Principal SponsorMethodist Health System
Study ContactColette N Ngo Ndjom, MSMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: May 4, 2023

Actual date on which the first participant was enrolled.

Male breast cancer (MBC) is a rare disease without sufficient clinical data supporting the management and treatment. The treatment of MBC arises from data extrapolated from female breast cancer (FBC). MBC has higher mortality than FBC. Previous studies have suggested differences between MBC and FBC; however, treatments remain the same for both. Larger studies in MBC are needed to provide more clinical data to help guide treatment.

Official TitleDemographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
NCT06133647
Principal SponsorMethodist Health System
Study ContactColette N Ngo Ndjom, MSMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

8 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 85 Years

Range of ages for which participants are eligible to join.

Conditions

Pathology

Breast Carcinoma In SituAdenocarcinomaBreast DiseasesBreast NeoplasmsCarcinomaCarcinoma in SituCarcinoma, Intraductal, NoninfiltratingNeoplasmsNeoplasms by Histologic TypeNeoplasms by SiteNeoplasms, Glandular and EpithelialSkin DiseasesSkin and Connective Tissue DiseasesCarcinoma, LobularNeoplasms, Ductal, Lobular, and Medullary

Criteria

Inclusion Criteria: * • ≥ 18 years of age Patients diagnosed with ductal carcinoma in situ or invasive lobular carcinoma of the breast Exclusion Criteria: * 18 years of age * Prisoners * Pregnant or breastfeeding

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Recruiting

Clinical Research Institute at Methodist Health System

Dallas, United StatesOpen Clinical Research Institute at Methodist Health System in Google Maps
Recruiting

Clinical Research Institute at Methodist Health System

Dallas, United States
Recruiting
2 Study Centers